Affymetrix said today it will postpone consideration of Thermo Fisher Scientific’s $1.3 billion acquisition offer for a week while considering a revised offer made for the company yesterday by Origin ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc., (NASDAQ:AFFX) announced today that it has acquired substantially all the assets of Hercules, CA-based Eureka Genomics ® Corporation for $15 ...
WILMINGTON, Delaware --A federal jury of eight will continue on Friday deliberations begun late Thursday on Oxford Gene Technology's allegation that Affymetrix's (AFFX) GeneChip product infringes on ...
Can a single word in a 35,000-word merger agreement cause a buyer to lose a deal to a higher bidder? In the case of Thermo Fisher Scientific Inc.’s pending buyout of Affymetrix Inc., it’s possible.
Unique and optimized solution provides highly sensitive and reproducible RNA amplification and labeling from archived FFPE samples for biomarker discovery and validation on industry-leading ...
SANTA CLARA, Calif.--(BUSINESS WIRE)-- Affymetrix, Inc. (NAS: AFFX) announced the launch of the new OncoScan™ FFPE Assay Kit, a whole-genome copy number assay for highly degraded FFPE solid tumor ...
Shares jump after the company's board approves a buyout offer from Thermo Fisher Scientific. So what: This transaction should help to grow Thermo's footprint in the red-hot area of biogenetic analysis ...
Collaboration to expand research and molecular breeding tools for enhancing plant, crop, and livestock production outcomes SANTA CLARA, Calif.--(BUSINESS WIRE)-- Affymetrix, Inc. (NASDAQ:AFFX), ...
Affymetrix' management team will host a conference call on April 27, 2011 at 2:00 p.m. PT to review its operating results for the first quarter of 2011. A live webcast can be accessed by visiting the ...
There's no foolproof way to know the future for Affymetrix (NAS: AFFX) or any other company. However, certain clues may help you see potential stumbles before they happen -- and before your stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results